National Cancer Center ( Site 2505) — Goyang-si, Kyonggi-do

Public research footprint of National Cancer Center ( Site 2505), compiled from the ClinicalTrials.gov public registry.

547

Registered studies

224

Active

107

Recruiting now

195

Completed

Stopped or withdrawn

Most-studied conditions

Non-small Cell Lung Cancer · Breast Neoplasms · Inoperable, Locally Advanced or Metastatic, ER-positive Breast Cancer · Triple Negative Breast Neoplasms

Recently updated registry entries

NCT06790693 — A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and… (Recruiting)
NCT04613596 — Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase… (Recruiting)
NCT04802759 — A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at National Cancer Center ( Site 2505)?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.